Incentivizing Therapies for Rare Diseases

被引：1
|
作者：
Karas, Laura [1 ]
机构：
[1] Harvard Pilgrim Hlth Care Inst, Dept Populat Med, 401 Pk Dr,Ste 401, Boston, MA 02215 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2019年 / 322卷 / 05期
关键词：
D O I：
10.1001/jama.2019.6954
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：464 / 465
页数：2
相关论文
共 50 条
  • [21] Therapies for rare diseases: therapeutic modalities, progress and challenges ahead
    Erik Tambuyzer
    Benjamin Vandendriessche
    Christopher P. Austin
    Philip J. Brooks
    Kristina Larsson
    Katherine I. Miller Needleman
    James Valentine
    Kay Davies
    Stephen C. Groft
    Robert Preti
    Tudor I. Oprea
    Marco Prunotto
    Nature Reviews Drug Discovery, 2020, 19 : 93 - 111
  • [22] Towards more therapies for rare diseases in a constrained health system
    Toumi, Mondher
    M S-MEDECINE SCIENCES, 2018, 34 : 45 - 47
  • [23] Protein Replacement Therapies for Rare Diseases: A Breeze for Regulatory Approval?
    Gorzelany, Jennifer A.
    de Souza, Mark P.
    SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (178)
  • [24] New ethical challenges in the management of rare pediatric diseases with innovative therapies
    Dufosset, M.
    Tosello, B.
    Le Coz, P.
    Chabrol, B.
    ARCHIVES DE PEDIATRIE, 2021, 28 (04): : 311 - 318
  • [25] Perspectives for improving the evaluation and access of therapies for rare lung diseases in Europe
    Luisetti, Maurizio
    Balfour-Lynn, Ian M.
    Johnson, Simon R.
    Miravitlles, Marc
    Strange, Charlie
    Trapnell, Bruce C.
    van Bronswijk, Hans
    Vogelmeier, Claus
    RESPIRATORY MEDICINE, 2012, 106 (06) : 759 - 768
  • [26] Personalization of therapies in rare diseases: a translational approach for the treatment of cystic fibrosis
    Villella, Valeria R.
    Tosco, Antonella
    Esposito, Speranza
    Ferrari, Eleonora
    Bona, Gianni
    Kroemer, Guido
    Raia, Valeria
    Maiuri, Luigi
    MINERVA PEDIATRICA, 2019, 71 (04) : 362 - 370
  • [27] Streamlined collaboration can boost CRISPR gene therapies for rare diseases
    He, Wei
    Zeng, Shuxiong
    Xu, Chuanliang
    NATURE, 2024, 631 (8019) : 28 - 28
  • [28] Are we prepared to deliver gene-targeted therapies for rare diseases?
    Yu, Timothy W.
    Kingsmore, Stephen F.
    Green, Robert C.
    MacKenzie, Tippi
    Wasserstein, Melissa
    Caggana, Michele
    Gold, Nina B.
    Kennedy, Annie
    Kishnani, Priya S.
    Might, Matthew
    Brooks, Phillip J.
    Morris, Jill A.
    Parisi, Melissa A.
    Urv, Tiina K.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2023, 193 (01) : 7 - 12
  • [29] Current state of developing advanced therapies for rare diseases in the European Union
    Qiu, Tingting
    Wang, Yitong
    Dabbous, Monique
    Hanna, Eve
    Han, Ru
    Liang, Shuyao
    Toumi, Mondher
    EXPERT OPINION ON ORPHAN DRUGS, 2020, 8 (10): : 417 - 429
  • [30] Data sharing to advance gene-targeted therapies in rare diseases
    Lekstrom-Himes, Julie
    Augustine, Erika F.
    Brower, Amy
    Defay, Thomas
    Finkel, Richard S.
    McGuire, Amy L.
    Skinner, Mark W.
    Yu, Timothy W.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2023, 193 (01) : 87 - 98
12345